-bresib
Cancer drugs that block BET bromodomain proteins.
- Drugs ending in -bresib: 9
- Approved somewhere: 0
- With a US drug page: 0
- Stem
- -bresib
- Class
- Cancer drugs that block BET bromodomain proteins
- Most common targets
- Bromodomain and extra-terminal motif (BET) (4)
Approved and clinical-stage drugs in ChEMBL whose names ending in -bresib, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Pelabresib | Phase 3 | Bromodomain and extra-terminal motif (BET) | Bromodomain and extra-terminal motif (BET) inhibitor |
| Amredobresib | Phase 2 | — | — |
| Birabresib | Phase 2 | Bromodomain and extra-terminal motif (BET) | Bromodomain and extra-terminal motif (BET) inhibitor |
| Molibresib | Phase 2 | Bromodomain and extra-terminal motif (BET) | Bromodomain and extra-terminal motif (BET) inhibitor |
| Sendegobresib | Phase 2 | — | — |
| Alobresib | Phase 1 | — | — |
| Ezobresib | Phase 1 | Bromodomain and extra-terminal motif (BET) | Bromodomain and extra-terminal motif (BET) inhibitor |
| Mivebresib | Phase 1 | — | — |
| Trotabresib | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO